Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRIVARACETAM vs BROLUCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BRIVARACETAM vs BROLUCIZUMAB: Safety Overview

Metric BRIVARACETAM BROLUCIZUMAB
Total FAERS Reports 6,098 682
Deaths Reported 317 41
Death Rate 5.2% 6.0%
Hospitalizations 1,536 105
Average Patient Age 40.6 yrs 69.5 yrs
% Female Patients 54.4% 57.1%
FDA Approval Date Dec 20, 2022 N/A
Manufacturer Aurobindo Pharma Limited Novartis Pharmaceuticals Corporation
Route ORAL INTRAVITREAL
Marketing Status Prescription N/A